<DOC>
	<DOCNO>NCT01853839</DOCNO>
	<brief_summary>This out-patient base prospective , multi-centre , observational post-marketing surveillance study amongst internist cardiologist . In study , patient essential hypertension least one additional risk factor include . Patients may take antihypertensive treatment approve cardiovascular protection include Micardis 80 mg / Micardis Plus . Patients follow one year four visit baseline endpoint additional visit month Ramadan .</brief_summary>
	<brief_title>Impact Ramadan Achieving Joint National Committee ( JNC ) 7 Treatment Goals CV Risk Patients</brief_title>
	<detailed_description>Purpose :</detailed_description>
	<criteria>Inclusion criterion : 1 . Male female age 18 year old ; 2 . Newly diagnose untreated previously treat uncontrolled patient essential hypertension ; 3 . Seated blood pressure &gt; 140/90 mmHg &gt; 130/80 mmHg patient diabetes mellitus chronic kidney disease ; 4 . Patients least one cardiovascular ( cv ) risk factor ; 5 . Ability provide write informed consent . Exclusion criterion : 1 . Patients contraindication prescribe antihypertensive medication ; 2 . Pregnant lactate woman woman childbearing potential use acceptable method contraception ; 3 . Patients participate study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>